home
portfolio
approach
team
careers
news
contact
investor portal
home
portfolio
approach
team
careers
news
contact
investor portal
Nextech Invest
Black Diamond Therapeutics Names Christopher Roberts, Ph.D., as Chief Scientific Officer
Black Diamond Therapeutics Names Christopher Roberts, Ph.D., as Chief Scientific Officer
Post navigation
Previous Post
Previous
Revolution Medicines Announces Dosing of First Patient in RMC-4630-02, a Phase 1b/2 Trial Combining RMC-4630 with a MEK Inhibitor
Next Post
Next
Black Diamond Therapeutics to Present Preclinical Data on its Lead Product Candidate BDTX-189 at the European Society for Medical Oncology 2019